GlassScriptPhysician profile
William L Burkhart
NPI 1700820123
$7,673.09
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,606 · 2020: $5,054 · 2024: $13.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,736.53 | 2019-2020 | |
| Amgen INC. | $335.48 | 2019-2020 | |
| Novo Nordisk INC | $313.21 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $298.10 | 2019-2020 | |
| Pfizer INC. | $275.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $265.08 | 2019-2020 | |
| Lilly USA, LLC | $214.23 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $212.49 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $193.41 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $170.23 | 2019-2020 | |
| Amarin Pharma, INC. | $153.35 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $146.75 | 2019-2020 | |
| Glaxosmithkline, LLC. | $113.57 | 2019 | |
| Zyla Life Sciences, INC. | $52.70 | 2019-2020 | |
| Circassia INC. | $34.41 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $29.65 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $28.34 | 2019-2020 | |
| Astellas Pharma US INC | $21.04 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.75 | 2019 | |
| Boston Scientific Corporation | $13.22 | 2024 | |
| Topcon Healthcare Solutions, INC. | $12.55 | 2019 | |
| Alkermes, INC. | $12.31 | 2019 | |
| Horizon Therapeutics Plc | $11.67 | 2020 | |
| Sanofi-Aventis U.S. LLC | $10.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Burkhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.